Update on credit rating of Eris Therapeutics Limited
Awaiting price reaction for this filing.
India Ratings & Research has assigned a credit rating of 'IND AA' with a Stable outlook to Eris Therapeutics Limited's additional bank facilities. IND AA is a high investment-grade rating, indicating strong financial health and low default risk. The agency has also affirmed (i.e., maintained) the existing ratings on the company's other borrowings at their current levels. This is a reissued version of a press release originally dated 05 May 2025, with updates to the instruments, limits, or amounts covered. The filing is made under SEBI's Listing Obligations and Disclosure Requirements regulations.
Positive for shareholders — the high IND AA rating and Stable outlook reflect strong creditworthiness of Eris Therapeutics, and the rating of additional facilities suggests expanded borrowing capacity at favorable terms. Existing ratings being affirmed signals continued financial stability, which generally supports investor confidence.